MTP-101-C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MTP-101-C, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC) [Phase 2]